SCHEMBL784884

SCHEMBL784884

Cc1cc(N2CCC(N(C)C(=O)c3ccc4c(c3)C(NC(=O)Nc3cccc(Cl)c3)CC4)CC2)cc(C)n1

nearest known ligand 0.41

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
TRPV1 Q8NER1 4/20 0.41
F10 P00742 1/20 0.41
JAK2 O60674 2/20 0.39
JAK1 P23458 1/20 0.39
NPY5R Q15761 1/20 0.39
USP30 Q70CQ3 1/20 0.38
EPHX2 P34913 2/20 0.38
ALDH1A1 P00352 1/20 0.38
KMT2A Q03164 3/20 0.37
LMNA P02545 2/20 0.37
MEN1 O00255 1/20 0.37
NPC1 O15118 1/20 0.37
EPHX1 P07099 1/20 0.37
TSHR P16473 1/20 0.37
RAB9A P51151 1/20 0.37
CCKBR P32239 1/20 0.37
TP53 P04637 1/20 0.36
MAPT P10636 1/20 0.36
PAK1 Q13153 1/20 0.36
FPR2 P25090 1/20 0.36

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL785571 0.93 F10 (0.41) TRPV1F10JAK2JAK1NPY5R
SCHEMBL784092 0.90 CCNC (0.42) TRPV1F10JAK2JAK1EPHX2
SCHEMBL785460 0.90 TRPV1 (0.41) TRPV1F10NPY5RALDH1A1KMT2A
SCHEMBL784725 0.89 F10 (0.40) TRPV1F10JAK2JAK1NPY5R
SCHEMBL785270 0.88 F10 (0.42) TRPV1F10ALDH1A1RAB9AMAPT
SCHEMBL785702 0.88 F10 (0.42) TRPV1F10USP30KMT2AMEN1
SCHEMBL785944 0.87 TRPV1 (0.41) TRPV1F10JAK2JAK1TSHR
SCHEMBL785210 0.87 USP30 (0.44) F10JAK2JAK1NPY5RUSP30
SCHEMBL785814 0.87 TAS1R3 (0.44) TRPV1F10JAK2JAK1EPHX2
SCHEMBL785738 0.86 ALDH1A1 (0.45) TRPV1F10JAK2JAK1NPY5R

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-8680159-B2 Bradykinin 1 receptor modulating compounds GRUENENTHAL GMBH (DE) 2014-03-25 US claimed
US-20120071461-A1 Substituted Benzamide Compounds GRUENENTHAL GMBH (DE) 2012-03-22 US claimed
US-8680159-B2 Bradykinin 1 receptor modulating compounds GRUENENTHAL GMBH (DE) 2014-03-25 US disclosed
US-20120071461-A1 Substituted Benzamide Compounds GRUENENTHAL GMBH (DE) 2012-03-22 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20120071461-A1 Substituted Benzamide Compounds BDKRB1, BDKRB2, HRH2 TRPV1 21/4885F10 524/4885JAK2 1298/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.